Radiopharm Theranostics Ltd SEC filings RDPTF
Radiopharm Theranostics Ltd has 163 filings in SEC EDGAR's recent list, going back to Dec 16, 2022. Its latest annual report, Form 20-F, was filed on Sep 30, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 27, 2026 | Oct 19, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 4, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 4, 2026 | — |
| 3 | Initial insider ownership | May 6, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | May 6, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 30, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 31, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 31, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 16, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 23, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 29, 2025 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RADX (Nasdaq), RDPTF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Carlton Vic
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1949257
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.